1h Free Analyst Time
The Clinical Trial Equipment & Ancillary Solutions Market size was estimated at USD 4.21 billion in 2023, USD 4.58 billion in 2024, and is expected to grow at a CAGR of 8.81% to reach USD 7.62 billion by 2030 . Speak directly to the analyst to clarify any post sales queries you may have.
Clinical trial equipment & ancillary solutions are specialized medical equipment and services used during clinical trials to accurately and effectively evaluate treatments, drugs, and devices. This equipment includes patient monitors, imaging systems, laboratory instruments, and automated data collection systems. It also includes ancillary services such as clinical trial management and regulatory support. Clinical trial equipment & ancillary solutions are essential components of any successful clinical trial as they provide the necessary tools and resources to ensure participants' safety and the trial results' accuracy. An ancillary solution for clinical trial equipment includes any tools, services, or products used to assist in completing a clinical trial. Rising investment in R&D activities for clinical trial equipment and ancillary solutions drives market growth by fueling innovation, improving data quality, expanding product offerings, ensuring regulatory compliance, addressing evolving trial needs, and attracting new market participants. Outsourcing clinical trial activities provides cost-effectiveness, access to expertise, expanded reach, streamlined operations, regulatory compliance, and scalability, further increasing the use of clinical trial equipment & ancillary solutions. Data security risks associated with cloud-based clinical trial solutions, such as unauthorized access and data breaches, create concerns about confidentiality, regulatory compliance, data integrity, and cybersecurity, hampering the clinical trial equipment & ancillary solutions market growth. Moreover, rising regulatory approvals for clinical trial equipment and government support, which increased trial activity, adoption of advanced technologies, innovation, and streamlined regulatory processes, have created market opportunities in the forecasted period.
Regional Insights
The clinical trials equipment & ancillary solutions market in the Americas is highly developing due to supportive governmental investments and initiatives for drug discovery and development and significant growth of clinical trial activities in the region. The Asia-Pacific region is an evolving market for clinical trial equipment & ancillary solutions owing to factors such as a large and diverse patient base and low costs that provide significant advantages for conducting clinical trials. Moreover, the stringent government norms in the EMEA region for ensuring the safety and efficacy of clinical trial equipment & ancillary solutions are making the market more competitive and standardized. The various government frameworks, including the European Medicines Agency (EMA), Clinical Trial Regulation 536/2014 (EU-CTR), and regional frameworks, monitor and regulate the use of clinical trial equipment & ancillary solutions in the region.Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
In clinical trials, ancillary supplies equipment refers to the specialized tools, devices, and instruments necessary for the clinical trials processes, operations, or system. Ancillary supplies provide essential advantages to clinical trials by enabling medical staff to accurately measure data points during a test. Laboratory equipment used in clinical trials includes centrifuges, autoclaves, incubators, cryogenic freezers, and spectrophotometers used to ensure accurate sample analysis. Imaging & diagnostics equipment includes X-ray machines, sonography machines, MRI scanners, CT scanners, spirometers, and laboratory analyzers. Diagnostic equipment used in clinical trials refers to the instruments and devices employed to diagnose, assess, and monitor participants' health status during the test.Ancillary sourcing services include equipment leasing & rental services, procurement, and supply & logistics, a service provided by clinical trial equipment and ancillary solutions providers that focuses on identifying, evaluating, and procuring the materials needed to support the success of a clinical trial. Supply & logistics ancillary sourcing services provide market research and analytical support to help clinical trial sponsors identify the optimal ancillary solutions for their trials. Data management & analysis services in clinical trials offer an organized way to collect, store, and analyze data related to the trial. Maintenance & calibration services in clinical trials are vital in ensuring the safety and accuracy of results achieved, which involve regular inspections, maintenance, and equipment calibration. Regulatory & compliance services in clinical trials are services and solutions that help ensure organizations comply with the rules, regulations, and standards established by a governing body. Site monitoring & support services in clinical trials involve providing ongoing support, monitoring, and oversight for research sites from the trial sponsor throughout the clinical trial process. Training & consulting services in clinical trials educate research staff and investigators on matters concerning best practices, safety procedures, and regulatory compliance. Moreover, a clinical trial management system is essential to effectively plan, manage, and track clinical study portfolios. An electronic data capture (EDC) system is a software application that helps streamline collecting, storing, and securing data from clinical studies.
Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
Medical device clinical trials are examinations undertaken to assess a medical device's safety or performance in terms of its use in treating, preventing, or diagnosing diseases in human subjects. In medical device clinical trials, equipment and ancillary solutions such as patient monitors, imaging systems, diagnostic tools, data management systems, and device calibration equipment ensure accurate evaluation and successful trial outcomes. Clinical trial equipment used in the manufacturing process of biological drugs offers numerous benefits, including increased efficiency and accuracy. In biological drugs, clinical trial equipment results in higher-quality data collection and analysis, which can increase overall efficiency and accuracy in drug production. The commonly used equipment in small molecule clinical trials include high-performance liquid chromatography (HPLC), ultra-high performance liquid chromatography (UHPLC), gas chromatography (GC), dissolution testing apparatus, automated dispensing systems, and centrifuges. Ancillary solutions utilized in the clinical trials space include sample handling, collection, storage, data analysis systems, software solutions for monitoring and tracking patient records, and sample safety and compliance.Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
Clinical trial equipment enhances the workflow of clinical investigation of blood disorders by providing computerized, highly specialized hematology analyzers for analyzing red and white blood cells, hemoglobin, and blood platelets in a blood sample. Clinical trial equipment such as the microscope, gastroscope, and duodenoscope is preferred in analyzing metabolic disorders and digestive disorders clinical trials to enhance the clinical outcomes during clinical investigation. Equipment and ancillary solutions are available for acute myelogenous leukemia, anemic cancer, and chronic myeloid leukemia disease conditions for oncology clinical studies. Medical imaging equipment and smart wearable devices are employed in the clinical trials of cardiovascular diseases, central nervous system (CNS) & mental disorders, infectious diseases, and metabolic disorders depending upon the indication to organize clinical trials effectively.Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
Phase I clinical trials primarily focus on assessing the security and dosage of a new drug or treatment. Equipment and ancillary solutions used in phase I trials include tools for dose administration, patient monitoring, and safety assessments. During phase I of the development process, pharmacokinetics and tolerance evaluations occur in a trial group comprising 100 people or less, including initial single-dose studies, dose-escalation, and repeated-dose studies in healthy volunteers. Phase II trials assess the effectiveness of a drug or therapy in a larger group of patients, between 100 and 500. The trial aims to discover the product’s preliminary efficacy and side effect profile. Phase III trials involve a larger patient population, around 3,000, and compare the new drug or treatment against existing standard therapies. Phase III trial takes an extended period to study the drug.End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
Clinical trial equipment and ancillary solutions are utilized in drug development, monitoring patient progress during a clinical trial executed by contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. Clinical trial equipment and ancillary solutions improve protocol adherence and ensure compliance with medical device companies' regulatory standards. Academic & research institutes provide educational support to participants and staff for optimum performance in clinical trials.Market Dynamics
The market dynamics represent an ever-changing landscape of the Clinical Trial Equipment & Ancillary Solutions Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.Market Disruption Analysis
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Clinical Trial Equipment & Ancillary Solutions Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Clinical Trial Equipment & Ancillary Solutions Market.Porter’s Five Forces Analysis
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Clinical Trial Equipment & Ancillary Solutions Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.Value Chain & Critical Path Analysis
The value chain of the Clinical Trial Equipment & Ancillary Solutions Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.Pricing Analysis
The pricing analysis comprehensively evaluates how a product or service is priced within the Clinical Trial Equipment & Ancillary Solutions Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Clinical Trial Equipment & Ancillary Solutions Market.Technology Analysis
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Clinical Trial Equipment & Ancillary Solutions Market.Patent Analysis
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Clinical Trial Equipment & Ancillary Solutions Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.Trade Analysis
The trade analysis of the Clinical Trial Equipment & Ancillary Solutions Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.Regulatory Framework Analysis
The regulatory framework analysis for the Clinical Trial Equipment & Ancillary Solutions Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Equipment & Ancillary Solutions Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Equipment & Ancillary Solutions Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Recent Developments
RQM+ Acquires Libra Medical
RQM acquired Libra Medical to expand its reach into more markets while providing its customers with access to Libra Medical's reliable and innovative product portfolio. With this acquisition, RQM continues its mission to provide high-quality and cost-effective clinical trial equipment and ancillary solutions to clients worldwide.Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
Lambda Therapeutics partnered with Medidata to automate and streamline its data management processes for greater clinical trial efficiency. Through advanced technology, Lambda Therapeutics manages its clinical trials more effectively and efficiently, allowing them to gather valuable insights from its data that can be used to make better decisions and enhance patient care outcomes.Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
MedNet launched its DICOM Imaging capabilities within the iMedNet eClinical platform. This addition allows trial sponsors and contract research organizations to manage clinical trials efficiently and securely by providing an integrated electronic data capture and imaging management solution. This expansion of MedNet's offerings provides researchers with a comprehensive suite of tools for collecting, managing, and analyzing data from clinical studies, ultimately improving the quality of care for patients. With this capability, MedNet enables clinical trial sponsors to move faster with greater visibility into image collections.Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Equipment & Ancillary Solutions Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.Key Company Profiles
The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systèmes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Lonza Group Ltd., MedNet Solutions, Inc., Myonex, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited.Market Segmentation & Coverage
This research report categorizes the Clinical Trial Equipment & Ancillary Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Equipment
- Imaging & Diagnostic Equipment
- Laboratory Equipment
- Services
- Ancillary Sourcing Services
- Equipment Leasing & Rental Services
- Procurement
- Supply & Logistics
- Data Management & Analysis Services
- Maintenance & Calibration Services
- Regulatory & Compliance Services
- Site Monitoring & Support Services
- Training & Consulting Services
- Ancillary Sourcing Services
- Systems
- Clinical Trial Management Systems
- Electronic Data Capture Systems
- Randomization & Trial Supply Management
- Equipment
- Type
- Biologic Drugs
- Medical Devices
- Small Molecules
- Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- End-Use
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations
- Medical Device Companies
- Indication
- Blood Disorders
- Cardiovascular Diseases
- CNS & Mental Disorders
- Digestive Disorders
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Oncology
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- United Arab Emirates
- United Kingdom
- Americas
This research report offers invaluable insights into various crucial aspects of the Clinical Trial Equipment & Ancillary Solutions Market:
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
5. Market Insights
6. Clinical Trial Equipment & Ancillary Solutions Market, by Product
7. Clinical Trial Equipment & Ancillary Solutions Market, by Type
8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase
9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use
10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication
11. Americas Clinical Trial Equipment & Ancillary Solutions Market
12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market
13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market
14. Competitive Landscape
15. Competitive Portfolio
List of Figures
List of Tables
Companies Mentioned
- Almac Group Limited
- Ancillare, LP
- Avantor, Inc.
- Axelerist
- B. Braun SE
- Bio-Rad Laboratories, Inc.
- Charles River Laboratories International, Inc.
- Dassault Systèmes SE
- Emsere B.V.
- Eppendorf SE
- Eurofins Scientific SE
- Global Vision Technologies, Inc.
- Hitachi, Ltd.
- IQVIA Holdings Inc.
- Lonza Group Ltd.
- MedNet Solutions, Inc.
- Myonex, Inc.
- Navitas Inc.
- Oracle Corporation
- Parexel International Corporation
- Quanticate International Limited
- Quipment SAS
- Royal Philips
- Thermo Fisher Scientific, Inc.
- United Parcel Service, Inc.
- Veeva Systems Inc.
- Yokogawa Electric Corporation
- Zifo Technologies Private Limited
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | May 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 4.58 Billion |
| Forecasted Market Value ( USD | $ 7.62 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
